March 15, 2018 | Israeli medical cannabis R&D company Kanabo Research announced yesterday that the Israeli Ministry of Health has granted its VapePod vaporizer product approval as a medical device, according to a statement. This move makes Israel the first country in the world to approve a vaporizer as a medical device for the use of medical cannabis extracts and formulations. Kanabo has already begun pre-clinical trials of the company’s current mixtures to be used with the VapePod medical cannabis vaporizer for the treatment of sleep disorders. The results are impressive in early findings, and the combination will give medical cannabis patients the opportunity to receive more effective and accurate dosage and delivery methods of medical cannabis treatment. Kanabo is in the process of registering two patents dealing with their formulations of medical cannabis extracts for sleep disorders to be used with the approved VapePod vaporizer. The VapePod medical vaporizer allows the patients to inhale their medical cannabis, without the risks of smoking, which is currently the most common way for patients to consume medical cannabis. “This approval is a significant announcement for the medical cannabis patients in Israel who will be able to use the medical vaporizer for the first time,” said Avihu Tamir, co-founder and CEO of Kanabo Research, who also added that as medical cannabis patients move to vaporizer usage, his company is expected to reach $10 million in sales in the Israeli market.